|
Market Pulse Breaking News Alert for Thursday, November 5, 2009: ARYC -- Arrayit Corporation to Diagnose Early Stage Cancers and Monitor Effectiveness of Treatments!
(Market Wire Via Acquire Media NewsEdge) ATLANTA, GA -- (MARKET WIRE) -- 11/05/09 --
Market Pulse News Alert for this AM, Stocks to
Watch are: Arrayit Corporation (OTCBB: ARYC), Merck & Co. Inc. (NYSE: MRK), ON Semiconductor Corp. (NASDAQ: ONNN) and American Lithium Minerals
Inc. (OTCBB: AMLM).
Investors need to be watching Arrayit Corporation (OTCBB: ARYC) this AM!
Arrayit Corporation is engaged in the development, manufacture, and
marketing of life science technologies and integrated systems for the
analysis of genetic variation, biological function, and diagnostics.
Arrayit offers a product line of approximately 650 tools to 2,500
laboratories worldwide. The company's products include microarrayers,
microarray scanners, DNA and protein microarrays, microarray printing,
microarray substrates and slides, microarray instruments, amplification and
labeling, purification kits, microarray hardware, buffers and solutions,
microarray cleanrooms, books and software, CGH microarrays, and microarray
platforms. Arrayit's worldwide business position leverages the company's
widely used patented microarray manufacturing platform and revolutionary
VIP(TM) genotyping technology. Nearly every major research center in the
world uses Arrayit products including research laboratories, pharmaceutical
companies, universities, biotechnology companies, hospitals, government
agencies, and nonprofit research organizations. The company is also
involved in the import, export, and distribution of industrial and food
grade chemicals for plastics, fertilizers, and green energy applications.
It has research collaboration with The Parkinson's Institute of Sunnyvale
to discover biomarkers for Parkinson's disease. ARYC recently announced
that it is developing a microarray-based diagnostic test to detect the H1N1
swine flu virus. The 2009 swine flu outbreak has raised concerns at the CDC
and the World Health Organization (WHO). The CDC and WHO believe that the
current outbreak poses a pandemic risk because the H1N1 flu virus contains
genetic elements from both the swine and human influenza viruses, allowing
direct human-to-human transmission without the need for agricultural
contact. Arrayit is an exciting and innovative public company that strives
to increase shareholder equity by inventing, developing, manufacturing and
supplying sophisticated life sciences products and services to an extensive
customer base spanning 50 countries. Arrayit is a leader in the field of
molecular diagnostics with patented technology that allows the screening
and monitoring of up to 80,000 patient samples on a single microscope
slide, rather than testing one patient per slide as is currently practiced.
Their corporate philosophy is embodied by a highly skilled,
multidisciplinary team of investors, business professionals, scientists,
engineers and executive and support staff who place shareholder value,
product quality, customer service and price competitiveness as their
highest priorities. Arrayit empowers decisive strategic advantage and large
return on investment for their customers in the research, pharmaceutical,
diagnostic, and health care markets! ARYC just had excellent news out in a
press release before today's opening bell announcing that they are pleased
to join the federal government in their efforts to help control health care
cost through early diagnosis of diseases! The company has issued several
positive press releases recently and on a technical note, Arrayit
Corporation's shares continue to act very well! This could be great news
for investors!
Arrayit Corporation (OTCBB: ARYC) is pleased to join the federal government
in their efforts to help control health care costs through early diagnosis
of diseases.
For more than 150 years, traditional medicine has relied on a 'standards of
care' model, which utilizes large cohorts of individuals as the data set
and essentially treats every person in an identical manner. While this
medical model provides a good paradigm for standard health care practices,
it is woefully deficient in that it fails to include genetic and epigenetic
differences between people as well as the interplay between our genes and
environmental factors including medication, diet and other lifestyle
considerations. In a major paradigm shift, personalized medicine is gaining
rapid popularity in that it endeavors to provide customized healthcare to
individuals inclusive of genetics, epigenetics and the environment, leading
to early stage diagnosis of diseases that have exacted a heavy cost in
quality and length of life and dollars spent in late stage treatment.
Personalized medicine is a vastly superior advance in health care if it can
be delivered at a rate equivalent to or less than the current standards of
care model. As a next generation healthcare company, Arrayit Corporation
is capable of delivering personalized medical information to the public at
a fraction of current costs, owing to the company's unique ability to
miniaturize, automate and massively parallelize genomic and proteomic
tests. In simple terms, these molecular diagnostic tests, requiring only a
blood sample, will be more accurate and less personally invasive than many
traditional cancer screening methods. Arrayit's patented microarray
manufacturing technology and Variation Identification Platform (VIP)
procedures, deployed in clinical laboratories and reference centers, are
capable of testing entire population groups. Arrayit personalized medical
tests for pre-symptomatic ovarian cancer detection, H1N1 screening, and
Parkinson's Disease diagnostics represent only a few of the collaborative
milestones soon to be announced.
About Arrayit Corporation
Arrayit Corporation, headquartered in Sunnyvale, California, leads and
empowers the genetic, research, pharmaceutical, and diagnostic communities
through the discovery, development and manufacture of proprietary life
science technologies and consumables for disease prevention, treatment and
cure. It now offers over 650 products to a customer base, including most
every major university, pharmaceutical and biotech company, major
agricultural and chemical company, government agency, national research
foundation and many private sector enterprises. Please visit
www.arrayit.com for more information.
Stocks in the news and acting well as of late include: Merck & Co.
Inc. (NYSE: MRK), ON Semiconductor Corp. (NASDAQ: ONNN) and American
Lithium Minerals Inc. (OTCBB: AMLM).
Information contained herein is the opinion of Market-Pulse.com ("MP") and
is intended to be used strictly for informational purposes. You should be
aware that MP attempts to assure itself of the accuracy of the information
contained in the analyses it publishes. In this regard, MP does, at times,
rely on the accuracy of information supplied to it by the companies which
are the subject of MP's analyses and/or parties related to those companies.
MP also relies on the accuracy
and integrity of information that is contained in company press releases
and reports filed with the SEC. The companies mentioned in this publication
have not approved the content or timing of the information being published
unless otherwise noted.
MP, because it relies on information supplied by various third parties
disclaims any responsibility for the accuracy of such information. Any
investor considering making an investment in any security which has been
the subject of a MP analysis or opinion should, before making any such
investment, consult with his/her market professional and/or do his/her own
independent research regarding the company which is the subject of an MP
opinion, recommendation or analysis.
Information regarding companies which MP has opined upon is normally
available from many sources including the subject company's filings with
the SEC and various press releases issued by the company.
You should be aware that MP is often compensated for issuing analyses,
recommendations or opinions concerning particular companies. Its opinion is
therefore not unbiased and you should consider this factor when evaluating
MP's statements regarding a company. MP has been compensated, in connection
with its profile of Arrayit Corporation, one hundred thousand shares of
Arrayit Corporation's common stock by a third party shareholder.
Additionally, MP bought for its own account in the open market, forty
thousand shares of Arrayit Corporation's shares for a total purchase price
of twenty three thousand eight hundred twenty dollars. To date, MP has sold
forty thousand shares of stock in Arrayit Corporation for proceeds totaling
twenty six thousand one hundred seventeen dollars. MP's officers and
directors reserve the right to buy additional shares of the companies
discussed in this opinion and may profit in the event those shares rise in
value. When MP receives shares as compensation for a profiled company, MP
may sell part or all of any such shares during the period in which MP is
performing such services. Market-Pulse.com and Market Pulse Breaking News
Alert are owned by Market Pulse LLC.
Contact:
Market Pulse
800.290.8935
Email Contact
[ Back To it.tmcnet.com's Homepage ]
|